Research ArticleOriginal Article
Open Access
Safety and efficacy of weekly somapacitan for growth hormone deficiency in children
A 72-week observational study
Abdulmoein E. Al-Agha, Hasan M. Aljefri, Shahd E. Kafi, Aliaa S. Alamri and Abdullah A. Alghamdi
Saudi Medical Journal March 2025, 46 (3) 269-273; DOI: https://doi.org/10.15537/smj.2025.46.3.20240937
Abdulmoein E. Al-Agha
From the Department of Pediatric (Al-Agha, Aljefri, Kafi, Alamri); and from the Department of Community Medicine (Alghamdi), King Abdulaziz University Hospital, Jeddah, Kingdom of Saudi Arabia.
DCH, FRCPCHHasan M. Aljefri
From the Department of Pediatric (Al-Agha, Aljefri, Kafi, Alamri); and from the Department of Community Medicine (Alghamdi), King Abdulaziz University Hospital, Jeddah, Kingdom of Saudi Arabia.
MBBS, MDShahd E. Kafi
From the Department of Pediatric (Al-Agha, Aljefri, Kafi, Alamri); and from the Department of Community Medicine (Alghamdi), King Abdulaziz University Hospital, Jeddah, Kingdom of Saudi Arabia.
MBBS, SB-PedsAliaa S. Alamri
From the Department of Pediatric (Al-Agha, Aljefri, Kafi, Alamri); and from the Department of Community Medicine (Alghamdi), King Abdulaziz University Hospital, Jeddah, Kingdom of Saudi Arabia.
MBBSAbdullah A. Alghamdi
From the Department of Pediatric (Al-Agha, Aljefri, Kafi, Alamri); and from the Department of Community Medicine (Alghamdi), King Abdulaziz University Hospital, Jeddah, Kingdom of Saudi Arabia.
MBBS
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Safety and efficacy of weekly somapacitan for growth hormone deficiency in children
Abdulmoein E. Al-Agha, Hasan M. Aljefri, Shahd E. Kafi, Aliaa S. Alamri, Abdullah A. Alghamdi
Saudi Medical Journal Mar 2025, 46 (3) 269-273; DOI: 10.15537/smj.2025.46.3.20240937
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.